First Reported Case of Ocrelizumab-Associated Leukocytoclastic Vasculitis in Primary Progressive Multiple Sclerosis: A Case Report
This case is the first reported instance of LCV associated with ocrelizumab in the treatment of multiple sclerosis. It underscores the need for awareness of potential drug-induced vasculitis in patients undergoing new or modified treatments and contributes to the growing understanding of adverse effects associated with ocrelizumab.
Authors
- Mohammadali Nahayati (ORCID: https://orcid.org/0000-0001-8373-6053)
- Amir Khanmirzaei (ORCID: https://orcid.org/0000-0003-4949-0306)
- Fatemeh Khosravani
- Mina Farahnezhad
Institutions
- Mashhad University of Medical Sciences (IR)
- Shahroud University of Medical Sciences (IR)
Publication Details
- Journal
- Case Reports in Neurology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1159/000548629
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Mashhad University of Medical Sciences